Lyka Labs Limited (NSE:LYKALABS)
India · Delayed Price · Currency is INR 57.84
-0.09 (-0.16%)
Jun 3, 2026, 3:27 PM IST
Lyka Labs Market Cap
Lyka Labs has a market cap or net worth of 2.07 billion as of June 3, 2026. Its market cap has decreased by -47.63% in one year.
Market Cap
2.07B
Enterprise Value
2.53B
Revenue
1.28B
Ranking
n/a
PE Ratio
n/a
Stock Price
57.84
Market Cap Chart
Since October 1, 2003, Lyka Labs's market cap has increased from 294.62M to 2.07B, an increase of 601.75%. That is a compound annual growth rate of 8.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 2.07B | -23.67% |
| Dec 31, 2025 | 2.71B | -51.91% |
| Dec 31, 2024 | 5.63B | 37.55% |
| Dec 29, 2023 | 4.09B | 10.05% |
| Dec 30, 2022 | 3.72B | -41.66% |
| Dec 31, 2021 | 6.38B | 617.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 688.86B |
| Anthem Biosciences | 423.48B |
| OneSource Specialty Pharma | 210.69B |
| Concord Biotech | 111.03B |
| Supriya Lifescience | 84.71B |
| Blue Jet Healthcare | 77.48B |
| Zota Health Care | 38.97B |
| Dishman Carbogen Amcis | 30.67B |